Computational design of a novel anti-inflammatory drug

PDF
Published: Mar 23, 2021
DOI: https://doi.org/10.12681/osj.26545
Keywords:
Computer-aided drug design ADME NSAID cyclooxygenase.
Maria Louvoulina
Evangeliki Model High School of Smyrna
Vasia Ekonomopoulou
Evangeliki Model High School of Smyrna
Maria Papageorgiou
Evangeliki Model High School of Smyrna
Abstract

Computer-aided drug design is among the most valuable tools we have in order to design new drug molecules. Herein, with the aid of the Drug Design Workshop platform, we describe our efforts to propose a new anti-inflammatory drug with a high selectivity upon the COX-2 target protein.

Article Details
  • Section
  • Greece
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Authors who publish with this journal agree to the following terms:

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution licence that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g. post it to a repository), with an acknowledgement of its initial publication in this journal.

Authors are permitted and encouraged to post their work online prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

Downloads
Download data is not yet available.
References
Rao, P. & Knaus, E. E. Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond. J. Pharm. Pharm. Sci. a Publ. Can. Soc. Pharm. Sci. Soc. Can. des Sci. Pharm. 11, 81s-110s (2008).
A. Laskowski, R. & B. Swindells, M. LigPlot+: Multiple Ligand–Protein Interaction Diagrams for Drug Discovery. J. Chem. Inf. Model. 51, 2778–2786 (2011).
T. Tavares, M. et al. Using an in Silico Approach To Teach 3D Pharmacodynamics of the Drug–Target Interaction Process Focusing on Selective COX2 Inhibition by Celecoxib. J. Chem. Educ. 94, 380–387 (2016).
Wang, J. L. et al. The novel benzopyran class of selective cyclooxygenase-2 inhibitors. Part 2: The second clinical candidate having a shorter and favorable human half-life. Bioorg. Med. Chem. Lett. 20, 7159–7163 (2010).
Rimon, G. et al. Coxibs interfere with the action of aspirin by binding tightly to one monomer of cyclooxygenase-1. Proc. Natl. Acad. Sci. 107, 28–33 (2010).
Lipinski, C. A., Lombardo, F., Dominy, B. W. & Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 46, 3–26 (2001).
Daina, A. et al. Drug Design Workshop: A Web-Based Educational Tool To Introduce Computer-Aided Drug Design to the General Public. J. Chem. Educ. 94, 335–344 (2017).
Daina, A., Michielin, O. & Zoete, V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 7, 42717 (2017).